Skip links

LYFGENIA™ (lovotibeglogene autotemcel)

 

Full Name LYFGENIA™ (lovotibeglogene autotemcel)
Drug lovotibeglogene autotemcel
Manufacturer Genetix Biotherapeutics Inc.
Route of Administration Intravenous
Site of Care Healthcare Facility
Approved Indication The treatment of patients 12 years of age or older with sickle cell disease and a history of vaso-occlusive events
Disease Sickle Cell Disease (SCD)
Therapeutic Area Hematology; Cell & Gene Therapy
Enrollment Information Visit lyfgeniahcp.com
Phone Number 847-849-1588
Fax Number 877-860-1726
Website lyfgeniahcp.com